Tumour necrosis factor-α gene polymorphisms and Alzheimer's disease
- 16 October 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 350 (1) , 61-65
- https://doi.org/10.1016/s0304-3940(03)00854-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Full genome screen for Alzheimer disease: Stage II analysis*American Journal of Medical Genetics, 2002
- Polymorphisms of the IL-6 gene increase the risk for late onset Alzheimer's disease and affected IL-6 plasma levelsNeurobiology of Aging, 2000
- Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein ENeurobiology of Aging, 2000
- Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activationProceedings of the National Academy of Sciences, 1997
- A polymorphic variation in a putative regulation box of the TNFA promoter regionImmunogenetics, 1994
- Neuroimmune Mechanisms in Alzheimer Disease PathogenesisAlzheimer Disease & Associated Disorders, 1994
- An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.The Journal of Experimental Medicine, 1993
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Apolipoprotein E genotyping by one-stage PCRThe Lancet, 1991
- Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proceedings of the National Academy of Sciences, 1989